MetLife Executive to Speak at Raymond James 47th Annual Institutional Investors Conference
MetLife, Inc. announced that Ramy Tadros, regional president of MetLife's U.S. Business and head of MetLife Holdings, will participate in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference. The event is scheduled for Wednesday, March 4, 2026, at 10:25 a.m. (ET). A live webcast and replay of the presentation will be available online.
Lincoln National (LNC) Maintains Quarterly Dividend of $0.45
Lincoln National Corporation (LNC) has declared a quarterly dividend of $0.45 per share, maintaining its previous payout, which results in a 4.49% forward yield. The company, a significant player in the financial services sector with a $7.62 billion market cap, is strategically focused on increasing spread-based annuity balances and improving free cash flow conversion. Despite some financial warning signs like a low Altman Z-Score and insider selling, its valuation metrics suggest potential undervaluation, though analyst sentiment is mixed.
MetLife, Inc. (MET) Announces Dividend Declarations on Preferred Stocks
MetLife, Inc. (MET) has announced dividend declarations for several of its preferred stock series. These include semi-annual and quarterly dividends for Series D, E, F, and A preferred stocks, each with specific liquidation preferences and payment structures. The declarations highlight MetLife's commitment to providing returns to its preferred shareholders.
MetLife Skills in Action: Empowering Non-Profits to Thrive
MetLife's "Skills for Impact" program leverages employee expertise to assist non-profit organizations like Volunteers of Legal Service in addressing critical operational challenges. The initiative exemplifies MetLife's belief in volunteering as a powerful force for good, enabling employees to apply their knowledge to strengthen communities. This program helps nonprofits thrive by building solutions and tackling mission-critical issues through skilled volunteerism.
The Hartford Insurance Group, Inc. (NYSE:HIG) Declares Quarterly Dividend of $0.60
The Hartford Insurance Group (NYSE:HIG) has declared a quarterly dividend of $0.60 per share, leading to an annualized dividend of $2.40 and a yield of 1.7%. The company has a strong record of increasing its dividend for 12 consecutive years, supported by a low payout ratio of 18.5%, indicating excellent coverage by earnings. Analysts anticipate continued growth for Hartford, projecting EPS of $11.11 for the current year and $12.67 for the next, with a consensus target price of $148.13.
Pzena Investment Management LLC Has $796.69 Million Stake in MetLife, Inc. $MET
Pzena Investment Management LLC increased its stake in MetLife, Inc. (NYSE:MET) by 5.8% in the third quarter, bringing their total holdings to 9,672,023 shares valued at approximately $796.69 million. MetLife recently reported strong quarterly earnings, beating EPS estimates, with revenue up 27.6% year-over-year, and declared a quarterly dividend. Analysts currently have a "Moderate Buy" consensus rating for MetLife with an average target price near $95.27.
Job Hugging" Is Undermining Workplace Outcomes: New MetLife Study
A new MetLife study reveals that increasing employee loyalty is often driven by necessity rather than true commitment, with 56% of workers staying in their jobs due to financial and job market uncertainties. This "job hugging" leads to lower engagement (only 18% stay because they truly want to) and reduced holistic health among employees. The study emphasizes that authentic connection at work, fostered by supportive cultures, leadership, and adaptive benefits, is crucial for improving employee well-being, engagement, and productivity beyond mere transactional loyalty.
MetLife Executive to Speak at Raymond James 47th Annual Institutional Investors Conference
MetLife, Inc. announced that Ramy Tadros, regional president of MetLife’s U.S. Business and head of MetLife Holdings, will speak at the Raymond James 47th Annual Institutional Investors Conference on March 4, 2026, at 10:25 a.m. ET. A live webcast of his presentation will be available online, with a replay accessible until March 11, 2026. This announcement highlights MetLife's engagement with the investment community alongside recent company news regarding employee retention and preferred stock dividends.
MetLife Executive to Speak at Raymond James 47th Annual Institutional Investors Conference
MetLife, Inc. announced that Ramy Tadros, regional president of MetLife’s U.S. Business and head of MetLife Holdings, will participate in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference. The event will take place on Wednesday, March 4, 2026, at 10:25 a.m. ET, and a live webcast will be available online for those who wish to listen. A replay of the presentation will also be accessible on MetLife's website until March 11, 2026.
One in three older Americans now doubt their retirement plans, CNO survey shows
A CNO Financial Group survey revealed that 32% of middle-income Americans aged 50-85 feel less confident about their retirement plans than a year ago, with 41% doubting they'll have enough money to live comfortably. Inflation is a top concern, influencing many to postpone retirement and leading to increased financial anxiety among pre-retirees. Furthermore, confidence in Social Security and Medicare is declining, with a significant number of respondents unsure about their future availability and many expecting Medicare cuts.
Job Hugging" Is Undermining Workplace Outcomes: New MetLife Study
A new MetLife study reveals that 56% of employees are staying in their jobs out of necessity rather than true commitment, a trend termed "job hugging." This lack of genuine connection leads to lower engagement, reduced holistic health, absenteeism, and decreased productivity, despite rising employee retention rates. The study emphasizes that fostering a sense of connection, being valued, and supported at work is crucial for improving employee well-being, engagement, and commitment, moving beyond transactional loyalty.
MetLife Settles Pension Math Class Action, Heading Off Trial
Metropolitan Life Insurance Co. has reached a settlement in a class-action lawsuit challenging its pension calculations for retirees. The agreement was made just one day before the trial was set to begin, avoiding a courtroom battle. This case is part of a larger trend of lawsuits scrutinizing how large employers use actuarial and interest rate assumptions for pension formats.
MetLife Declares $29.375 Semi-Annual Dividend with Strong Yield
MetLife has announced a semi-annual dividend of $29.375 per share, resulting in a strong forward yield of 74.76%, demonstrating its robust cash flow and dedication to shareholder returns. The company also declared quarterly dividends for its Series E and Series F preferred stocks and plans a dividend for its floating-rate Series A preferred stock, contingent on financial tests. These declarations, alongside its "New Frontier" strategy targeting $25 billion in free cash flow and double-digit adjusted EPS growth, reflect MetLife's confidence in its future financial stability and long-term growth potential.
MetLife, Inc. $MET Stock Position Boosted by Skandinaviska Enskilda Banken AB publ
Skandinaviska Enskilda Banken AB publ significantly increased its stake in MetLife, Inc. (NYSE:MET) by 31.3% in the third quarter, now owning 369,648 shares valued at approximately $30.45 million. Analysts have largely positive sentiment, with a consensus "Moderate Buy" rating and an average price target of $95.27. MetLife also reported strong quarterly earnings, beating EPS estimates, and declared a quarterly dividend of $0.5675 per share, representing an annualized yield of about 2.9%.
Vanguard Group Inc. Buys 7,578,199 Shares of MetLife, Inc. $MET
Vanguard Group Inc. increased its stake in MetLife, Inc. (NYSE:MET) by 13.3% in the third quarter, acquiring an additional 7,578,199 shares and now owning 9.74% of the company. Other institutional investors also adjusted their positions in MetLife. The article also provides details on MetLife's stock performance, recent earnings, upcoming dividend, and analyst ratings, which currently indicate a "Moderate Buy" consensus.
F&G Annuities & Life (FG) Q4 2025 Earnings: Revenue & EPS Projections - News and Statistics
F&G Annuities & Life (NYSE:FG) is set to release its Q4 2025 financial results after market close on Thursday. Analysts project revenues of $1.55 billion, a 2.9% year-on-year decrease, with adjusted earnings of $1.20 per share. Despite an anticipated revenue dip, analysts have maintained stable estimates, and the company's stock has seen a 6.1% increase over the last month, outperforming the life insurance sector's average.
F&G Annuities & Life Earnings: What To Look For From FG
F&G Annuities & Life (NYSE:FG) is set to report earnings after market hours on Thursday. Analysts expect a 2.9% year-on-year revenue decline to $1.55 billion and adjusted earnings of $1.20 per share. Despite mixed past performance against revenue estimates, current analyst sentiment is positive, with an average price target of $32 against a current share price of $28.57.
MetLife Announces First-Quarter 2026 Preferred Stock Dividends
MetLife, Inc. (MET) has declared preferred stock dividends for the first quarter of 2026 across its Series D, E, F, and A. These dividends will be payable on March 16, 2026, to shareholders of record as of February 27, 2026, signaling the company's financial capacity and commitment to income-focused investors. An analyst has a "Buy" rating on MET stock with a $91.00 price target, and TipRanks' AI Analyst, Spark, rates MET as Neutral due to stable financials, constructive earnings, and reasonable valuation with an attractive dividend.
MetLife Announces First Quarter 2026 Preferred Stock Dividend Actions
MetLife, Inc. (NYSE: MET) has declared preferred stock dividends for the first quarter of 2026, including semi-annual and quarterly dividends for its Series D, E, and F preferred stocks. A quarterly dividend for Series A preferred stock was also declared, subject to final confirmation of financial tests around March 5, 2026. The dividends are payable on March 16, 2026, to shareholders of record as of February 27, 2026.
How Investors Are Reacting To Unum Group (UNM) Buybacks Amid Sharply Lower Net Income
Unum Group reported sharply lower net income in its fourth-quarter and full-year 2025 results, despite an increase in revenue and the completion of a significant share buyback program. This decline in profitability raises concerns among investors about the resilience of Unum's earnings and its ability to consistently support dividends and future buybacks without straining profit margins. While the company's long-term growth forecasts remain positive, the wide range of fair value estimates from the Simply Wall St Community highlights investor uncertainty regarding the sustainability of Unum's earnings power.
MetLife, Inc. $MET Shares Sold by Aberdeen Group plc
Aberdeen Group plc recently decreased its holdings in MetLife, Inc. by 8.4% in the third quarter, selling 75,275 shares but still retaining 816,287 shares valued at $66.56 million. Despite this sale, other institutional investors like Norges Bank, ABN AMRO Bank N.V., Amundi, Man Group plc, and Worldquant Millennium Advisors LLC significantly increased their stakes in MetLife. The company also declared a quarterly dividend of $0.5675 per share, payable on March 10th.
AlphaQuest LLC Has $57,000 Position in MetLife, Inc. $MET
AlphaQuest LLC significantly reduced its stake in MetLife, Inc. (NYSE:MET) by 98.1% in the third quarter, holding 697 shares valued at $57,000. Despite this reduction, other institutional investors either increased their holdings or acquired new stakes in MetLife. The company recently reported strong quarterly earnings, beating analyst estimates, declared a quarterly dividend, and received a "Moderate Buy" consensus rating from analysts with an average target price of $95.42.
MetLife Inc Is Suddenly Everywhere – But Is This Old-School Giant Still Worth Your Money?
MetLife Inc (MET) is presented as a stable, dividend-paying investment option despite not being a viral "hype" stock. The article analyzes MET's business model as an insurance and benefits provider, its stock performance, and the risks involved (interest rates, recessions, regulation). It concludes that MetLife is a strong "cop" for long-term investors seeking defensive plays and steady income, offering stability away from volatile tech stocks.
Varma Mutual Pension Insurance Co Boosts Stake in MetLife, Inc. $MET
Varma Mutual Pension Insurance Co increased its stake in MetLife, Inc. (NYSE:MET) by 21.9% in Q3, now holding 137,956 shares valued at $11.36 million. Other significant institutional investors also either initiated or boosted their positions. MetLife recently reported strong Q3 earnings, beating EPS estimates, with revenue up 27.6% year-over-year, and declared a quarterly dividend.
MetLife 2023 Sustainability Report: Demonstrating Employee Care
MetLife's 2023 Sustainability Report highlights its commitment to employee care, emphasizing its "All Together Possible" Employee Value Proposition. The report details how genuine interest in employee well-being leads to better talent management and business performance. MetLife was certified as a Great Place to Work® in 11 markets and achieved high scores in internal employee surveys regarding culture and well-being.
MetLife Inc Is Suddenly Everywhere – But Is This Old-School Giant Still Worth Your Money?
MetLife Inc. (MET) is presented as a stable, dividend-paying "boomer stock" that offers financial security and wealth-building potential for long-term investors, despite not being a viral or high-hype asset. The article highlights MetLife's defensive stock nature, consistent dividend history, and reliable business model based on insurance and benefits, contrasting it with high-volatility tech stocks. It concludes that while not flashy, MetLife can be a crucial balancing component in a diversified portfolio, especially in uncertain markets.
LSV Asset Management Has $134.45 Million Stock Position in MetLife, Inc. $MET
LSV Asset Management recently reduced its stake in MetLife, Inc. (NYSE:MET) by 2.7%, now holding 1,632,300 shares valued at $134.45 million. Despite this reduction, other institutional investors have either increased their holdings or initiated new positions in the financial services provider. MetLife reported strong Q4 earnings, beating analyst estimates, and announced a quarterly dividend of $0.5675 per share.
Rhumbline Advisers Sells 20,428 Shares of MetLife, Inc. $MET
Rhumbline Advisers reduced its stake in MetLife, Inc. by 1.9% in the third quarter, selling 20,428 shares and now owning 1,040,543 shares worth $85.7 million. Other institutional investors have also adjusted their holdings in MetLife, which has a "Moderate Buy" consensus rating and a target price of $95.42 from analysts. The company recently reported strong quarterly earnings, beating analyst estimates, and declared a quarterly dividend.
MetLife, Inc. $MET Holdings Cut by Freemont Management S.A.
Freemont Management S.A. significantly reduced its stake in MetLife, Inc. by 88.0%, selling 27,100 shares and retaining 3,700 shares valued at approximately $305,000. Despite this, other major institutions like Norges Bank, Invesco, Amundi, Nordea, and Swedbank increased their holdings, leading to institutional investors owning around 94.99% of the company. Analysts maintain a "Moderate Buy" rating for MetLife with an average price target of $95.42, significantly higher than the current share price of $77.28, and the company recently beat quarterly EPS estimates.
Caprock Group LLC Invests $2.58 Million in MetLife, Inc. $MET
Caprock Group LLC has acquired a new stake worth approximately $2.58 million in MetLife, Inc. (NYSE:MET) during the third quarter. Other institutional investors like Norges Bank, Invesco Ltd., Nordea Investment Management AB, Amundi, and Swedbank AB have also adjusted their holdings in MetLife, with institutional investors owning 94.99% of the company's stock. Analysts currently rate MetLife as a "Moderate Buy" with an average price target of $95.42.
Root, Inc. (NASDAQ:ROOT) Might Not Be As Mispriced As It Looks After Plunging 26%
Root, Inc. (NASDAQ:ROOT) shareholders have experienced a significant 26% drop in share price over the last month, contributing to a 50% loss over the past year. Despite this plunge, the company's P/S ratio of 0.6x is comparable to the industry median of 1.1x, which may imply that the stock is not as mispriced as it appears. Analysts forecast an 11% annual revenue growth for Root over the next three years, outpacing the industry's 5.2%, yet its P/S ratio remains modest, suggesting investor skepticism about future growth stability.
MetLife Foundation Reaches New Milestone, Over $1 Billion in Giving
MetLife Foundation announced it has surpassed $1 billion in charitable giving since its establishment in 1976. The Foundation focuses on inclusive economic mobility and addressing the needs of underserved communities globally, impacting financial health and well-being. This milestone was celebrated with a food packing event in partnership with Food Bank For New York City, and recognized by New York City Mayor Eric Adams.
Trupanion (NASDAQ:TRUP) Posts Q4 CY2025 Sales In Line With Estimates
Trupanion (NASDAQ:TRUP) reported Q4 CY2025 sales of $376.9 million, meeting Wall Street's revenue expectations with an 11.7% year-on-year increase. However, its GAAP profit of $0.13 per share missed analyst estimates by 19.6%. The company's revenue growth has an impressive five-year compounded annual growth rate of 23.4%, although its two-year annualized growth is slightly lower at 13.9%.
Manulife to cancel up to 42 million of its own shares in new buyback
Manulife (TSX/NYSE: MFC) announced its intention to launch a Normal Course Issuer Bid (NCIB) to repurchase and cancel up to 42 million common shares, representing approximately 2.5% of its outstanding shares. This move, awaiting Toronto Stock Exchange acceptance but already approved by OSFI, is part of its capital management strategy to enhance shareholder value. The company plans to use various purchase methods, including market transactions, private agreements, and derivative-based programs.
Mizuho Adjusts Price Target on MetLife to $100 From $102, Maintains Outperform Rating
Mizuho Securities has revised its price target for MetLife (MET) shares to $100 from the previous $102, while reiterating an "Outperform" rating on the stock. This adjustment comes amidst other analyst revisions for MetLife shares recently. MetLife's business operations include life, accident, health, and property & casualty insurance, with significant presence in the United States and Japan.
ProShare Advisors LLC Sells 13,189 Shares of MetLife, Inc. $MET
ProShare Advisors LLC significantly reduced its stake in MetLife, Inc. (NYSE:MET) by selling 13,189 shares, decreasing its position by 9.1% in the third quarter. Despite this, institutional investors collectively own 94.99% of MetLife's stock. The article also provides a comprehensive financial overview of MetLife, including its stock performance, recent earnings beat, dividend announcement, and various analyst ratings with a consensus "Moderate Buy" rating.
Impax Asset Management Group plc Has $13.64 Million Stock Position in Voya Financial, Inc. $VOYA
Impax Asset Management Group plc reduced its stake in Voya Financial, Inc. (NYSE:VOYA) by 46.4% in the third quarter, holding 182,379 shares valued at $13.64 million. Despite Impax's reduction in shares, other hedge funds increased their positions in Voya Financial. The asset manager reported mixed financial results, missing EPS estimates but exceeding revenue expectations for the last quarter, and announced a quarterly dividend.
Manulife earnings on deck as AI investments meet insurer test By Investing.com
Manulife Financial Corp. is set to announce its Q4 2025 earnings, with analysts expecting a sequential pullback despite a strong Q3. Investors will be closely watching the impact of Manulife's AI investments on efficiency gains and whether the company can balance aggressive shareholder returns with necessary technology and growth investments. The broader life insurance sector is currently on solid footing, supported by favorable demographics, high interest rates, and strong equity markets.
Evercore ISI Adjusts Price Target on MetLife to $95 From $97, Maintains In Line Rating
Evercore ISI has adjusted its price target for MetLife (MET) to $95, down from $97, while maintaining an "In Line" rating on the stock. This update reflects a re-evaluation by the analyst firm, following recent financial presentations and other analyst revisions for the insurance giant. The article also notes other recent analyst actions on MetLife, indicating active re-assessment of the company's valuation.
The Bull Case For MetLife (MET) Could Change Following Rising Revenue, Falling Earnings And Ongoing Buybacks
MetLife recently reported a mixed financial performance with a rise in Q4 2025 revenue to US$23,814 million, but a notable decrease in net income to US$809 million. The company also completed a significant share repurchase of over US$1.1 billion. This combination of higher revenue, lower earnings, and continued buybacks presents a nuanced view for investors, suggesting a potential shift in the investment narrative as the company balances shareholder returns with margin resilience and asset volatility risks.
5 Insightful Analyst Questions From MetLife's Q4 Earnings Call
MetLife's Q4 2025 results showed revenue below Wall Street expectations but adjusted EPS higher than anticipated, driven by strong performances in group benefits, pension risk transfer, and international growth. This article highlights five key questions analysts posed during the earnings call, covering topics such as group benefits trends, real estate accounting changes, retail retirement strategy, AI's impact on employment, and disability results. The article also touches upon future catalysts for MetLife, including PineBridge integration and international sales growth.
Precision Trading with Metlife Inc. (MET) Risk Zones
This article analyzes Metlife Inc. (MET), highlighting a weak near-term sentiment that could lead to bearish positioning. It details a strong 17.7:1 risk-reward setup targeting a 5.2% gain against a 0.3% risk. The analysis includes three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods, along with multi-timeframe signal analysis.
Candriam S.C.A. Sells 193,802 Shares of MetLife, Inc. $MET
Candriam S.C.A. significantly reduced its stake in MetLife, Inc. (NYSE:MET) by selling 193,802 shares, decreasing its holdings by 71.6% to 76,885 shares valued at $6.33 million. Despite this, other institutional investors have increased their positions in MetLife. The article also provides MetLife's recent financial performance, analyst ratings indicating a "Moderate Buy" consensus, dividend information, and market performance metrics.
Inside AFLAC Inc.: How a Boring-Sounding Insurer Became a Quiet Tech Product Powerhouse
AFLAC Inc., traditionally seen as an insurer, has transformed into a tech-driven protection platform, offering supplemental insurance as an integrated product. It focuses on event-based cash benefits, digital claims, and employer-centric distribution, differentiating itself through specialization, brand recognition, and a strong Japanese franchise. This strategic evolution positions AFLAC Inc. as a leader in the supplemental insurance market, contributing to its strong stock performance.
1 Insurance Stock with Impressive Fundamentals and 2 Facing Headwinds
This article identifies one insurance stock positioned for sustainable growth and two others facing significant headwinds. MetLife (MET) and Equitable Holdings (EQH) are recommended for selling due to limited growth potential, declining book values, and increased expenses. Conversely, Erie Indemnity (ERIE) is highlighted as a compelling buy due to its impressive revenue growth, strong book value per share growth, and stellar return on equity.
MetLife 2023 Sustainability Report: Promoting Financial Stability and Wellness
MetLife's 2023 Sustainability Report showcases its commitment to promoting financial stability and wellness through various initiatives. The report highlights MetLife 360Health and 360Future programs, which offer comprehensive services for physical, mental, and financial health, and support retirement planning. It also details collaborations to enhance employee benefits understanding and access to mental health and bereavement support, alongside its pet insurance program's community involvement.
MetLife price target lowered to $95 from $97 at Evercore ISI
Evercore ISI has reduced its price target for MetLife (NYSE:MET) stock to $95 from $97, while maintaining an "In Line" rating. This adjustment follows MetLife's Q4 2025 results and 2026 outlook, although Evercore ISI kept its 2026 and 2027 EPS estimates unchanged, noting that the price target change primarily reflects an "uneconomic" accounting modification related to real estate. Despite the reduced target, the new price still suggests a potential 22% upside from the current price.
MetLife price target lowered to $95 from $97 at Evercore ISI
Evercore ISI has reduced its price target for MetLife (NYSE:MET) to $95 from $97, maintaining an "In Line" rating. This adjustment follows MetLife's fourth-quarter 2025 results and 2026 outlook, although the firm kept its 2026 and 2027 earnings per share estimates unchanged. The price target change is primarily due to an "uneconomic" accounting modification related to real estate depreciation, which will lower corporate loss but marginally reduce free cash flow conversion.
MetLife price target lowered to $95 from $97 at Evercore ISI
Evercore ISI has reduced its price target for MetLife (NYSE:MET) stock to $95 from $97, while maintaining an "In Line" rating. This adjustment follows the company's fourth-quarter 2025 results and 2026 outlook announcement, yet the new target still implies a 22% upside from the current trading price. The change primarily reflects an accounting modification related to real estate depreciation, which analysts view as "uneconomic" but beneficial for lowering corporate loss without impacting free cash flows.
Half of Retirees Fear Running Out of Money as Pressures on U.S. Retirement Security Intensify, MetLife Research Finds
MetLife's 2026 Paycheck or Pot of Gold Study reveals a significant rise in retirement anxiety, with 58% of pre-retirees and 51% of retirees concerned about outliving their defined contribution plan savings due to rising healthcare costs and increased longevity. The study highlights that savings are depleting faster, especially for those taking lump sum withdrawals, and that guaranteed income solutions like annuities are increasingly seen as essential for financial stability in retirement. Both pre-retirees and retirees are seeking more guidance, indicating a growing awareness of the need for reliable income streams.
